Patents by Inventor Richard L. Fenichel

Richard L. Fenichel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for modulating the immune response with dibenzocycloheptenylidenes
    Patent number: 4376124
    Abstract: A method of modulating the immune response in mammals by administering thereto compounds having the general formula: ##STR1## where R is hydrogen or alkyl of 1-4 carbon atoms, R.sup.1 is hydrogen or an alkyl of 1-4 carbon atoms and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: March 8, 1982
    Date of Patent: March 8, 1983
    Assignee: American Home Products Corporation
    Inventors: Richard P. Carlson, Richard L. Fenichel, Alan J. Lewis, Milton Wolf
  • 4-Amino-2-substituted-5-pyrimidinecarboxamidoximes and carbothioamides
    Patent number: 4323681
    Abstract: 4-Amino-2-substituted-5-pyrimidinecarboxamidoximes and carbothioamides are immunomodulatory agents useful in the treatment of immune system diseases and disorders.
    Type: Grant
    Filed: September 29, 1980
    Date of Patent: April 6, 1982
    Assignee: American Home Products Corporation
    Inventors: Milton Wolf, Richard L. Fenichel
  • Thiazolo[3,2-a]benzimidazoles, imidazo [2,1-b]thiazoles, and related compounds as antineoplastic agents, and enhancers of the immune response
    Patent number: 4214089
    Abstract: The use of 3-aryl-thiazolo[3,2-a]benzimidazoles, 3-aryl-imidazo[2,1-b]thiazoles, and related compounds as antineoplastic agents, and/or as enhancers of the immune response is disclosed.
    Type: Grant
    Filed: July 18, 1978
    Date of Patent: July 22, 1980
    Assignee: American Home Products Corporation
    Inventors: Richard L. Fenichel, Peter H. L. Wei, Francis J. Gregory, Harvey E. Alburn
  • Long acting somatostatin composition
    Patent number: 4041155
    Abstract: An aqueous vehicle containing about 80% polyethylene glycol 400 or polyethylene glycol 300 imparts long-acting growth hormone release inhibiting activity to somatostatin or linear somatostatin.
    Type: Grant
    Filed: October 29, 1974
    Date of Patent: August 9, 1977
    Assignee: American Home Products Corporation
    Inventors: Richard L. Fenichel, Howard J. Levin
  • Prostaglandin intermediate
    Patent number: 3979446
    Abstract: The topical application of 7-(5.alpha.-hydroxy-2.beta.-[(3RS)-3-hydroxy-3-methyl-trans-1-octenyl]-3.a lpha.-methyl-1.alpha.-cyclopentyl)-cis-5-heptenoic acid, 7-(5.alpha.-hydroxy-2.beta.-[(3RS)-3-hydroxy-3-methyl-trans-1-octenyl]-1.a lpha.-cyclopentyl)-cis-5-heptenoic acid, or 7-(2.beta.-[(3RS)-hydroxy-3-methyl-trans-1-octenyl]-5-oxo-1.alpha.-cyclope ntyl)-cis-5-heptenoic acid to a wound surface can be employed to attenuate bleeding. The compounds are prepared from the prostaglandin PGA.sub.2.
    Type: Grant
    Filed: April 11, 1975
    Date of Patent: September 7, 1976
    Assignee: American Home Products Corporation
    Inventors: Donald P. Strike, Wenling Kao, Richard L. Fenichel